RAND's divisions conduct research on a uniquely broad front for clients around the globe.
Most relevant regions
Research
Jan 21, 2026
This study evaluates the integration of a COVID-19 symptom checker into an asthma-focused mHealth application.
Expert Insights
Jan 13, 2026
In this paper, the authors aim to understand what the world needs to spend annually to prepare for and respond to emerging respiratory pandemic diseases resulting from different modes of transmission: respiratory, insect-vectored, and fluid-borne.
Dec 22, 2025
To understand what supports good practice in the implementation and use of technology-enabled remote monitoring in the chronic obstructive pulmonary disease care pathway and draw transferable lessons that can inform spread and scale up.
Oct 10, 2025
To understand factors associated with low vaccination coverage, a web-based survey was conducted among risk-eligible adults examining their knowledge, attitudes, and practices toward pneumococcal vaccination.
Apr 28, 2025
In response to 2012 studies enhancing a deadly pathogen's transmissibility, the U.S. and research community established policies to oversee research on enhanced pathogens with pandemic potential.
Apr 23, 2025
This randomized controlled trial of a scalable symptom monitoring intervention found an increase in asthma-related quality of life but it did not reach the threshold for a minimally important change.
Commentary
Dec 23, 2024
The ongoing H5N1 outbreak presents a critical test of America's ability to apply the hard-earned lessons of recent health emergencies. The time to act is not when the threat becomes unmanageable—it is now, when swift, coordinated efforts can make the greatest impact.
Nov 15, 2024
The cover story explores a new examination of military and veteran caregivers that provides updated estimates of the number of adults caregiving in the U.S. today; and provides insights on the health, economic security, and well-being of caregivers.
Aug 14, 2024
This study describes and quantifies the burden of respiratory syncytial virus (RSV) in the United Kingdom in adults to the patients, the health and care systems and the economy. The total economic cost is estimated to be around £319m annually.
Project
Aug 6, 2024
RAND Europe researchers estimate that 11,800 adult deaths per year in the UK are due to Respiratory Syncytial Virus (RSV), and it may be a contributing factor in further deaths.
Jul 9, 2024
The authors analyzed data from two large nationally representative health surveys that permit comparisons of the prevalence of respiratory disease diagnoses and symptoms between veterans and their civilian peers.
Nov 15, 2023
Study providing an overview of the pathogen surveillance space, involved stakeholders, strengths and weaknesses of initiatives, challenges of pathogen surveillance, and how data has been used to inform public health decision making.
